The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
A Colne man who lost his football scholarship in America due to a ketamine addiction is warning people about the dangers of ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
Recreational ketamine use has increased in the United States in recent years, outpacing its rise as a treatment for depression, a new analysis suggests. The hallucinogenic drug — a controlled ...